About journal

About China Oncology

• JOURNAL OF CHINA ONCOLOGY

  
  Description 
  The journal of China Oncology (ISSN 1007-3639, CN 31-1727/R) started in 1991, is a peer-reviewed monthly publication, integrating scientific information from global sources for all oncologic specialties. It is an open access monthly published journal in Chinese and English. The competent authorities of China Oncology is the Ministry of Education of the People’s Republic of China. China Oncology is hosted by one of the most prestigious comprehensive cancer centers, the Fudan University Shanghai Cancer Center. 

  
  

  Database Index

  At present, China Oncology is indexed in the following most powerful database: SCOPUS, DOAJ, Chemical Abstracts (CAS), EMBASE, EBSCO, Japan Science and Technology Database (JST), Index of Copernicus International (ICI), EuroPub and Western Pacific Region Index Medicus (WPRIM),  Ulrich's Periodical Directory, Chinese Science Citation Database (CSCD), A Guide to the Core Journal of China, Chinese Scientific and Technical Papers and Citations Database (CSTPCD), Chinese Academic Journal Comprehensive Evaluation Database (CAJCED), Chinese Medical Current Content (CMCC), Chinese Medical Citation Index (CMCI),Chinese Biological Abstracts (CBA), GoOA, COAJ, Level A of Fudan University degree and Graduate Education Domestic Journals Guideline, Research Center for Chinese Science Evaluation (RCCSE), World Journal Clout Index (WJCI) Report of Scientific and Technological Periodicals (up to 2024). Besides, China Oncology continuously acquired Certificate of Outstanding S&T Journals of China (F5000) since 2017. 
  

  
  

  Besides, China Oncology achieved lots of prizes during the past years. According to the latest statistical data in 2019 released by Institute of Scientific and Technical Information of China (ISTIC), the impact factor of China Oncology in Chinese Journal Citation Reports (Extended Version) was 4.903. Meanwhile, Chinese Journal Citation Report (Core Version) data showed that the core impact factor ranked fourth among the journals on oncology (IF=3.471). Besides, the IF of China Oncology ranked 2nd in oncologic subject in Chinese Science Citation Database (CSCD). China Oncology is now in a leading position in Chinese Journals in China.
  

  
  

  Aims and scope
  

  As a leading comprehensive oncology journal in China, the objective of China Oncology is to provide an interdisciplinary forum for the exchange of information among oncologic disciplines.

  China Oncology achieves this objective by publishing original research contents on basic medicine, clinical medicine, epidemiology, etc., with the columns of research articles, editorial comments, review, guidelines and case report.  In addition, China Oncology also publishes special themed issues that present solicited review articles of current interest authored by globally recognized clinical oncologists and scientists. The special themed issues are published at least 2 times annually. 

  
  

  China Oncology publishes interdisciplinary oncologic information according to, but not limited to, the following disease sites and disciplines:
     Blood/bone marrow
     Breast disease
     Epidemiology
     Pathology
     Diagnosis of cancer
     Gastrointestinal tract
     Genitourinary disease
     Gynecologic oncology
     Head and neck cancer
     Hepatobiliary malignancies
     Lung cancer
     Medical oncology
     Radiation oncology
     Surgical oncology
     Neuro-oncology
     Translational research 

  
  

  Readership
  Surgical, medical, and radiation oncologists; gynecologists; urologists; pathologists, diagnostic radiologists; basic scientists in oncology; epidemiologists.

  
  

  Open Access License Statement

  China Oncology is a peer reviewed, open access journal. All content of the journal is published under the Creative Commons Attribution-Non-Commercial-NoDerivs 4.0 (CC-BY-NC-ND 4.0). All articles published open access will be immediately and permanently free for all to read, download, copy and distribute as defined by the applied license.

  Free access and usage 

  Permitted the third party to reuse is defined by the CC-BY-NC-ND 4.0 license. This license allows users to copy and distribute the article, provided:
  · This is not done for commercial purposes and further does not permit distribution of the Article if it is changed or edited in any way.
  · The user gives appropriate credit (with a link to the formal publication through the relevant DOI) and provides a link to the license but not in an any way implying that the licensor is endorsing the user or the use of the work.
  · No derivatives including remix, transform, or build upon the material was allowed for distribution.
  The full details of the license are available at https://creativecommons.org/licenses/by-nc-nd/4.0/

  
  

  Editor-in-Chief

  Prof. SHAO Zhimin 

  
  

  Honorary Editor-in-Chief
  Prof. TANG Zhaoyou, Prof. CAO Shilong, Prof. SHEN Zhenzhou

  
  

  Competent Authorities
  The Ministry of Education of the People’s Republic of China

  
  

  Sponsored by
  Fudan University Shanghai Cancer Center
  

  
  

  Edited by
  Editorial Board of China Oncology

  
  Director of the Editorial Department
  NI Ming

  
  Editorial Office
  Journal of China Oncology
  Fudan University Shanghai Cancer Center 270 Dong’an Road Shanghai, 200032

  The People’s Republic of China

  
  

2024-04-28 Visited: 157419